Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 62, Issue 9, 2010, Pages 2767-2775

  Scalzi, Lisabeth V ^a   Hollenbeak, Christopher S ^a   Wang, Li ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; MORTALITY; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREND STUDY; AGE; CAUCASIAN; CAUSE OF DEATH; COMORBIDITY; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; ONSET AGE; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; UNITED STATES;

AFRICAN AMERICANS; AGE FACTORS; AGE OF ONSET; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSPITALIZATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SOCIAL CLASS; SURVIVAL RATE; UNITED STATES;

EID: 77956374706     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27551     Document Type: Article

References (23)

1. Anderson E, Nietert PJ, Kamen DL, Gilkeson GS. Ethnic disparities among patients with systemic lupus erythematosus in South Carolina. J Rheumatol 2008;35:819-25. (Pubitemid 351747122)
2. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
3. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
4. Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). February 2010. Agency for Healthcare Research and Quality, Rockville, MD.
5. Hart AC, Stegman MS, Ford B (eds). ICD-9-CM Expert for physicians. 6th edition. Salt Lake City: Ingenix; 2006.
6. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
7. Manhapra A, Canto JG, Vaccarino V, Parsons L, Kiefe CI, Barron HV, et al. Relation of age and race with hospital death after acute myocardial infarction. Am Heart J 2004;148:92-8.
8. Dittrich H, Gilpin E, Nicod P, Cali G, Henning H, Ross J Jr. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988;62:1-7.
9. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15.
10. Haque S, Gordon C, Isenberg D, Rahman A, Lanyon P, Bell A, et al. Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study. J Rheumatol 2010;37:322-9.
11. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:338-46.
12. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus: negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990;33:37-48. (Pubitemid 20040128)
13. Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 1985;64:285-95.
14. Sharma S, Malarcher AM, Giles WH, Myers G. Racial, ethnic and socioeconomic disparities in the clustering of cardiovascular disease risk factors. Ethn Dis 2004;14:43-8.
15. Shah MA, Shah AM, Krishnan E. Poor outcomes after acute myocardial infarction in systemic lupus erythematosus. J Rheumatol 2009;36:570-5.
16. Urowitz MB, Gladman DD, Ibanez D, Berliner Y. Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study. Ann Rheum Dis 2006;65:115-7.
17. Bruce IN, Gladman DD, Urowitz MB. Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study. Clin Exp Rheumatol 1998;16:435-40.
18. Sonel AF, Good CB, Mulgund J, Roe MT, Gibler WB, Smith SC Jr, et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?). Circulation 2005;111:1225-32.
19. Condon JV, Miller KM, Le AH, Quasem M, Looney SW. Acute myocardial infarction and race, sex, and insurance types: unequal processes of care. Health Care Manag (Frederick) 2008;27:212-22.
20. Zerwic JJ, Ryan CJ, DeVon HA, Drell MJ. Treatment seeking for acute myocardial infarction symptoms: differences in delay across sex and race. Nurs Res 2003;52:159-67.
21. Disparities in adult awareness of heart attack warning signs and symptoms: 14 states, 2005. MMWR Morb Mortal Wkly Rep 2008;57:175-9.
22. Jha AK, Staiger DO, Lucas FL, Chandra A. Do race-specific models explain disparities in treatments after acute myocardial infarction? Am Heart J 2007;153:785-91.
23. Yood MU, McCarthy BD, Kempf J, Kucera GP, Wells K, Oliveria S, et al. Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy. Am Heart J 2006;152:777-84.